2022 Q4 Form 10-Q Financial Statement
#000121390022072147 Filed on November 14, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
Revenue | $54.19K | $275.0K | |
YoY Change | -97.36% | ||
Cost Of Revenue | $33.00K | ||
YoY Change | |||
Gross Profit | $127.6K | -$5.825K | |
YoY Change | -2290.68% | -100.17% | |
Gross Profit Margin | 46.4% | ||
Selling, General & Admin | $219.7K | $476.8K | $363.4K |
YoY Change | -40.01% | 31.21% | 20.39% |
% of Gross Profit | 373.66% | ||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $198.5K | $198.3K | $138.6K |
YoY Change | 36.81% | 43.01% | 0.27% |
% of Gross Profit | 155.37% | ||
Operating Expenses | $417.7K | $476.8K | $363.4K |
YoY Change | 14.06% | 31.21% | 20.39% |
Operating Profit | -$349.2K | -$369.2K | |
YoY Change | -5.42% | -111.9% | |
Interest Expense | -$59.02K | $452.9K | -$485.1K |
YoY Change | -126.43% | -193.35% | 734.97% |
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $452.9K | $1.726M |
YoY Change | -100.0% | -73.76% | 172497.0% |
Pretax Income | -$488.7K | $103.7K | $871.6K |
YoY Change | -159.38% | -88.11% | 1656.59% |
Income Tax | -$14.14K | ||
% Of Pretax Income | |||
Net Earnings | -$474.6K | $103.7K | $871.6K |
YoY Change | -157.67% | -88.11% | 1656.59% |
Net Earnings / Revenue | -875.81% | 37.7% | |
Basic Earnings Per Share | $0.02 | $0.16 | |
Diluted Earnings Per Share | -$0.09 | $0.02 | $1.323K |
COMMON SHARES | |||
Basic Shares Outstanding | 5.333M shares | 5.332M shares | 5.333M shares |
Diluted Shares Outstanding | 5.333M shares | 6.587M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $90.60K | $75.97K | $213.9K |
YoY Change | -65.79% | -64.48% | 132.78% |
Cash & Equivalents | $90.60K | $75.97K | $213.9K |
Short-Term Investments | |||
Other Short-Term Assets | $5.321K | $13.09K | $15.53K |
YoY Change | -56.76% | -15.7% | 60.93% |
Inventory | |||
Prepaid Expenses | $5.321K | ||
Receivables | $215.6K | $670.00 | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $95.92K | $304.6K | $230.1K |
YoY Change | -65.39% | 32.4% | -88.21% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | $1.131M | $1.330M | |
YoY Change | 109.67% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $1.131M | $1.330M | $1.786M |
YoY Change | 109.67% | -25.56% | -23.65% |
TOTAL ASSETS | |||
Total Short-Term Assets | $95.92K | $304.6K | $230.1K |
Total Long-Term Assets | $1.131M | $1.330M | $1.786M |
Total Assets | $1.227M | $1.634M | $2.016M |
YoY Change | 50.26% | -18.94% | -53.02% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $148.5K | $193.1K | $112.3K |
YoY Change | 14.76% | 71.99% | -95.86% |
Accrued Expenses | $904.6K | $787.7K | $413.8K |
YoY Change | 83.87% | 90.35% | -57.03% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $5.591M | $5.422M | $3.288M |
YoY Change | -9.02% | 64.89% | 2136.73% |
Long-Term Debt Due | $2.797M | $2.804M | $2.805M |
YoY Change | -0.3% | -0.05% | -39.97% |
Total Short-Term Liabilities | $9.586M | $9.410M | $10.48M |
YoY Change | 14.08% | -10.22% | 10.65% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $150.0K | $147.6K | $150.0K |
YoY Change | 0.0% | -1.6% | -13.28% |
Other Long-Term Liabilities | $53.67K | $190.0K | $190.0K |
YoY Change | -71.75% | 0.0% | -83.9% |
Total Long-Term Liabilities | $203.7K | $337.6K | $340.0K |
YoY Change | -40.1% | -0.71% | -74.88% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $9.586M | $9.410M | $10.48M |
Total Long-Term Liabilities | $203.7K | $337.6K | $340.0K |
Total Liabilities | $9.790M | $9.748M | $10.82M |
YoY Change | 11.97% | -9.92% | -0.04% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$26.19M | -$25.71M | |
YoY Change | 2.96% | ||
Common Stock | $160.00 | $160.00 | |
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$8.563M | -$8.114M | -$8.805M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.227M | $1.634M | $2.016M |
YoY Change | 50.26% | -18.94% | -53.02% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$474.6K | $103.7K | $871.6K |
YoY Change | -157.67% | -88.11% | 1656.59% |
Depreciation, Depletion And Amortization | $198.5K | $198.3K | $138.6K |
YoY Change | 36.81% | 43.01% | 0.27% |
Cash From Operating Activities | -$150.2K | -$260.2K | -$146.9K |
YoY Change | -122.75% | 77.18% | -80.94% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | -$442.0K | $0.00 |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$442.0K | $0.00 |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 164.8K | 550.0K | 200.0K |
YoY Change | -377.51% | 175.0% | |
NET CHANGE | |||
Cash From Operating Activities | -150.2K | -260.2K | -146.9K |
Cash From Investing Activities | 0.000 | -442.0K | 0.000 |
Cash From Financing Activities | 164.8K | 550.0K | 200.0K |
Net Change In Cash | 14.63K | -152.2K | 53.15K |
YoY Change | -71.29% | -386.34% | -106.9% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$150.2K | -$260.2K | -$146.9K |
Capital Expenditures | $0.00 | -$442.0K | $0.00 |
Free Cash Flow | -$150.2K | $181.8K | -$146.9K |
YoY Change | -112.41% | -223.81% | -80.94% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q3 | us-gaap |
Revenues
Revenues
|
usd | |
us-gaap |
Other Income
OtherIncome
|
usd | ||
CY2021Q3 | qprc |
Warrant Expenses
WarrantExpenses
|
usd | |
qprc |
Warrant Expenses
WarrantExpenses
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
33-18099-NY | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
11-2873662 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
411 Theodore Fremd Ave | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 206S | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Rye | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10580-1411 | ||
dei |
City Area Code
CityAreaCode
|
(888) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
743-7577 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5333347 | shares |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
75968 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
264840 | usd |
CY2022Q3 | us-gaap |
Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
|
0 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
|
0 | usd |
CY2022Q3 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
215571 | usd |
CY2022Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
13092 | usd |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
12305 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
304631 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
277145 | usd |
CY2022Q3 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
1427345 | usd |
CY2021Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
715519 | usd |
CY2022Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1329655 | usd |
CY2021Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
539481 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
1634286 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
816626 | usd |
CY2022Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
193135 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
129426 | usd |
CY2022Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
138000 | usd |
CY2021Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
138000 | usd |
CY2022Q3 | qprc |
Funding Liability
FundingLiability
|
5283714 | usd |
CY2021Q4 | qprc |
Funding Liability
FundingLiability
|
3202765 | usd |
CY2022Q3 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
2801150 | usd |
CY2021Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
2805000 | usd |
CY2022Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2402 | usd |
CY2022Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
204042 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1636187 | usd |
CY2022Q3 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
787676 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
491971 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9410119 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8403349 | usd |
CY2022Q3 | qprc |
Loans Payable Sba
LoansPayableSba
|
147598 | usd |
CY2021Q4 | qprc |
Loans Payable Sba
LoansPayableSba
|
150000 | usd |
CY2022Q3 | qprc |
Purchase Price Of Patents
PurchasePriceOfPatents
|
190000 | usd |
CY2021Q4 | qprc |
Purchase Price Of Patents
PurchasePriceOfPatents
|
190000 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
9747717 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
8743349 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00003 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00003 | |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00003 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00003 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5333347 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5333347 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5333347 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5333347 | shares |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
160 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
160 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
17601077 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
17508867 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-25714896 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-25435978 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8113659 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7926951 | usd |
CY2022Q3 | us-gaap |
Minority Interest
MinorityInterest
|
228 | usd |
CY2021Q4 | us-gaap |
Minority Interest
MinorityInterest
|
228 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-8113431 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-7926723 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1634286 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
816626 | usd |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
275000 | usd |
us-gaap |
Revenues
Revenues
|
397000 | usd | |
CY2022Q3 | qprc |
Litigation And Licensing Expenses
LitigationAndLicensingExpenses
|
147393 | usd |
CY2021Q3 | qprc |
Litigation And Licensing Expenses
LitigationAndLicensingExpenses
|
5825 | usd |
qprc |
Litigation And Licensing Expenses
LitigationAndLicensingExpenses
|
237487 | usd | |
qprc |
Litigation And Licensing Expenses
LitigationAndLicensingExpenses
|
70063 | usd | |
CY2022Q3 | us-gaap |
Gross Profit
GrossProfit
|
127607 | usd |
CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
-5825 | usd |
us-gaap |
Gross Profit
GrossProfit
|
159513 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
-70063 | usd | |
CY2022Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
476812 | usd |
CY2021Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
363402 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1561987 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3482360 | usd | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
476812 | usd |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
363402 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
1561987 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
3482360 | usd | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-349205 | usd |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-369227 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1402474 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3552423 | usd | |
CY2021Q3 | us-gaap |
Other Income
OtherIncome
|
1725965 | usd |
us-gaap |
Other Income
OtherIncome
|
1763573 | usd | |
qprc |
Warrant Expenses
WarrantExpenses
|
1154905 | usd | |
CY2022Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-565928 | usd |
CY2021Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
394610 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1432145 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
779645 | usd | |
qprc |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
-305556 | usd | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-730378 | usd | |
CY2022Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-113058 | usd |
CY2021Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-90509 | usd |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-295705 | usd | |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-216667 | usd | |
CY2022Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
452870 | usd |
CY2021Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1240846 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1136440 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1423578 | usd | |
CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
103665 | usd |
CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
871619 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-266034 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4976001 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
12884 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1806 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
103665 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
871619 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-278918 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4977807 | usd | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.99 | ||
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | |
CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.99 | ||
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5046016 | shares | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5333347 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6587167 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5333347 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5046016 | shares | |
CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-6841678 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
1248000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
555556 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
598188 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
262285 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5156792 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-9334441 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
294830 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-692634 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-9732245 | usd |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
55448 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
871619 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-8805178 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-7926723 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
42079 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-162640 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-8047284 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
24928 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-219943 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-8242299 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
25203 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
103665 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-8113431 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-278918 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4977807 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
74541 | usd | |
qprc |
Change In Fair Market Value Of Warrant Liabilitys
ChangeInFairMarketValueOfWarrantLiabilitys
|
-1432145 | usd | |
qprc |
Change In Fair Market Value Of Warrant Liabilitys
ChangeInFairMarketValueOfWarrantLiabilitys
|
779645 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
92210 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1860563 | usd | |
us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
1154905 | usd | |
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
1763573 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
711826 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1014777 | usd | |
qprc |
Loss On Conversions Of Debt
LossOnConversionsOfDebt
|
305556 | usd | |
us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
730378 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
215571 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1032219 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
787 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
9597 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
63709 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-1053766 | usd | |
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
295705 | usd | |
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
142128 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-763971 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-710031 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1502000 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
600000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1502000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-600000 | usd | |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-3850 | usd | |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-1750000 | usd | |
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
-9000 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
2103000 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
3150000 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
22051 | usd | |
qprc |
Payments To Acquire Purchase Price Of Patents
PaymentsToAcquirePurchasePriceOfPatents
|
114951 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2077099 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1276049 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-188872 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-33982 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
264840 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
247862 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
75968 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
213880 | usd |
qprc |
Shares Issued For Conversion Of Debt
SharesIssuedForConversionOfDebt
|
555556 | usd | |
qprc |
Interest Added To Principal
InterestAddedToPrincipal
|
4208 | usd | |
qprc |
Interest Added To Principal
InterestAddedToPrincipal
|
4208 | usd | |
qprc |
Options Granted For Settlement Of Debt
OptionsGrantedForSettlementOfDebt
|
598188 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
12884 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | ||
us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
13000 | usd | |
us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
2000 | usd | |
us-gaap |
Revenue Recognition Allowances
RevenueRecognitionAllowances
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patent Licensing Fees</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers”. Revenue is recognized when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Under Topic 606, revenue is recognized when there is a contract which has commercial substance which is approved by both parties and identifies the rights of the parties and the payment terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the periods presented, revenue contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company’s operating subsidiaries as part of the settlement of litigation commenced by the Company’s subsidiaries. Intellectual property rights granted included the following, as applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted were perpetual in nature, extending until the legal expiration date of the related patents. The individual intellectual property rights are not accounted for as separate performance obligations, as (a) the nature of the promise, within the context of the contract, is to transfer combined items to which the promised intellectual property rights are inputs and (b) the Company’s promise to transfer each individual intellectual property right described above to the customer is not separately identifiable from other promises to transfer intellectual property rights in the contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the promised intellectual property rights are not individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted for all of the intellectual property rights promised in the contract as a single performance obligation. The intellectual property rights granted were “functional IP rights” that have significant standalone functionality. The Company’s subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. The Company’s subsidiaries have no further obligation with respect to the grant of intellectual property rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e. transfer of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally obtain control of the intellectual property rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 30 to 90 days of execution of the contract. Contractual payments made by licensees are generally non-refundable. The Company does not have any significant payment terms, as payment is received shortly after goods are delivered or services are provided, therefore there is no significant financing component or consideration payable to the customer in these transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | ||
qprc |
Warrants Granted
WarrantsGranted
|
962463 | shares | |
qprc |
Purchase Agreement Stock Options
PurchaseAgreementStockOptions
|
500000 | shares | |
qprc |
Stock Options Granted To Officers And Consultants
StockOptionsGrantedToOfficersAndConsultants
|
600000 | usd | |
CY2021Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1150000 | usd |
CY2021Q3 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
1726000 | usd |
CY2021Q4 | us-gaap |
Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
|
138000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
103665 | usd |
CY2021Q3 | us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
871619 | usd |
us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
-278918 | usd | |
us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
-4977807 | usd | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5333347 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5046016 | shares | |
CY2021Q3 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
1253820 | usd |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5333347 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6587167 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5333347 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5046016 | shares | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.99 | ||
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | |
CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.99 | ||
CY2021Q3 | qprc |
Outstanding Option
OutstandingOption
|
1500000 | shares |
CY2022Q3 | us-gaap |
Retained Earnings Appropriated
RetainedEarningsAppropriated
|
25715000 | usd |
qprc |
Negative Working Capital
NegativeWorkingCapital
|
9105000 | usd | |
CY2022Q3 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.10 | pure |
us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
719000 | usd | |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
962463 | shares |
CY2021 | qprc |
Carrying Amount As Of The Restructure Date
CarryingAmountAsOfTheRestructureDate
|
4672810 | usd |
CY2021 | qprc |
Net Carrying Amount
NetCarryingAmount
|
4672810 | usd |
CY2021 | qprc |
Cash Payment
CashPayment
|
-1750000 | usd |
qprc |
Warrants Description
WarrantsDescription
|
Exercisability of the warrant is limited if, upon exercise, the holder or any of holder’s affiliates would beneficially own more than 4.99% (the “Maximum Percentage”) of the Company’s common stock, except that by written notice to the Company, the holder may change the Maximum Percentage to any other percentage not in excess of 9.99% provided any such change will not be effective until the 61st day following notice to the Company. The warrant also contains certain minimum ownership percentage antidilution rights pursuant to which the aggregate number of shares of common stock purchasable upon the initial exercise of the warrant shall not be less than 10% of the aggregate number of outstanding shares of capital stock of the Company (determined on a fully diluted basis). | ||
CY2021Q1 | qprc |
Agreement Description
AgreementDescription
|
On February 26, 2021, the Company entered into an agreement with Peter K. Trzyna (“PKT”) pursuant to which PKT assigned to the Company all right, title, and interest in a portfolio of eight United States patents (the “Peregrin Portfolio”). Under the agreement, the Company paid PKT $350,000 at closing and agreed that upon the realization of gross proceeds, if any, the Company shall make a second installment payment or payments in the aggregate amount of $93,900 representing reimbursement to PKT, as the prosecuting attorney, for legal fees associated with prosecution of the portfolio, such reimbursement shall be due and payable to PKT from time to time as gross proceeds are realized, and paid to PKT along with and in proportion to reimbursement to other third parties of costs incurred in realizing gross proceeds from the Peregrin Portfolio. Thereafter, PKT is entitled to a percentage of gross proceeds realized, if any, from the Peregrin Portfolio. The Company requested and received a capital advance from QFL in the amount of $350,000 pursuant to the Purchase Agreement, which was used to make payment to PKT. | |
CY2021Q2 | qprc |
Taasera Licensing Llc Description
TaaseraLicensingLLCDescription
|
On May 20, 2021, TLL, entered into an agreement with Taasera, Inc. to acquire all right, title, and interest in a portfolio of seven United States patents (the “Taasera Portfolio”) for $250,000. The Company requested and received a capital advance from QFL in the amount of $250,000 pursuant to the Purchase Agreement, which was used to make payment to Taasera, Inc. | |
qprc |
Purchase Agreement
PurchaseAgreement
|
92000 | usd | |
CY2022Q3 | qprc |
Purchase Price Percentage
PurchasePricePercentage
|
0.50 | pure |
CY2022Q3 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
350000 | usd |
CY2022Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
35000 | usd |
us-gaap |
Notes Issued1
NotesIssued1
|
250000 | usd | |
us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
1750000 | usd | |
qprc |
Loss On Debt Conversion
LossOnDebtConversion
|
305556 | usd | |
qprc |
Asset Acquired Description
AssetAcquiredDescription
|
(v) Pursuant to the MPA-NA, until the TMPO has been paid in full, Intelligent Partners is entitled to receive 10% of the net proceeds realized from new assets acquired by the Company. If, in any calendar quarter, net proceeds realized exceed $1,000,000, Intelligent Partners’ entitlement for that quarter only shall increase to 30% on the portion of net proceeds in excess of $1,000,000 but less than $3,000,000. If in the same calendar quarter, net proceeds exceed $3,000,000, Intelligent Partners’ entitlement for that quarter only shall increase to 50% on the portion of net proceeds in excess of $3,000,000. | ||
qprc |
Common Stock Description
CommonStockDescription
|
(vi) The Company granted Intelligent Partners, Fitton and Carper certain registration rights with respect to (i) the 500,000 shares currently owned by Fitton and Carper; (ii) the 462,963 Conversion Shares issued to Fitton and Carper, and (iii) the 500,000 shares of common stock issuable upon exercise of the option. See Note 5. | ||
qprc |
Excess Amount
ExcessAmount
|
Events of Default include (i) a Change of Control of the Company (ii) any uncured default on payment due to Intelligent Partners in an amount totaling in excess of $275,000, which is not the subject of a Dispute or other formal dispute resolution proceeding initiated in good faith pursuant to this Agreement or other Restructure Documents (iii) the filing of a voluntary petition for relief under the United States Bankruptcy Code by Company or any of its material subsidiaries, (iv) the filing of an involuntary petition for relief under the United States Bankruptcy Code against the Company, which is not stayed or dismissed within sixty (60) days of such filing, except for an involuntary petition for relief filed solely by Intelligent Partners, or any Affiliate or member of Intelligent Partners, or (v) acceleration of an obligation in excess of $1,000,000 to another provider of financing following a final determination by arbitration or other judicial proceeding that such obligation is due and owing. | ||
qprc |
Loss On Extinguishment Note
LossOnExtinguishmentNote
|
730378 | usd | |
CY2021 | qprc |
Conversion Of Transferred Note
ConversionOfTransferredNote
|
-250000 | usd |
CY2021 | qprc |
Fair Value Of Option Grant
FairValueOfOptionGrant
|
-598188 | usd |
CY2021 | qprc |
Undiscounted Future Cash Flows
UndiscountedFutureCashFlows
|
-2805000 | usd |
CY2021 | qprc |
Loss On Extinguishment
LossOnExtinguishment
|
-730378 | usd |
CY2020Q2 | us-gaap |
Derivative Maturity Dates
DerivativeMaturityDates
|
2020-05-14 | |
CY2020Q1 | qprc |
Deducted Loan Amount
DeductedLoanAmount
|
100 | usd |
CY2020Q1 | qprc |
Loan Origination Cost
loanOriginationCost
|
1000 | usd |
qprc |
Acquisition Funding
AcquisitionFunding
|
95000 | usd | |
qprc |
Funder Received
FunderReceived
|
190000 | usd | |
CY2021Q1 | us-gaap |
Shares Issued
SharesIssued
|
962463 | shares |
CY2021Q1 | qprc |
Warrant Yield Percentage
WarrantYieldPercentage
|
0.10 | pure |
CY2021Q1 | qprc |
Aggregate Number Of Outstanding Shares
AggregateNumberOfOutstandingShares
|
0.10 | pure |
CY2022Q3 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
204000 | usd |
CY2021Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
1636000 | usd |
qprc |
Fair Value Assumption Expected Volatility Rate
FairValueAssumptionExpectedVolatilityRate
|
3.75 | pure | |
qprc |
Fair Value Assumption Expected Volatility Rate
FairValueAssumptionExpectedVolatilityRate
|
3.73 | pure | |
qprc |
Fair Value Exercise Price
FairValueExercisePrice
|
0.54 | ||
qprc |
Fair Value Exercise Price
FairValueExercisePrice
|
0.54 | ||
qprc |
Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
|
0.0137 | pure | |
qprc |
Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
|
0.0137 | pure | |
qprc |
Fair Value Assumption Expected Term
FairValueAssumptionExpectedTerm
|
P8Y4M24D | ||
qprc |
Fair Value Assumption Expected Term
FairValueAssumptionExpectedTerm
|
P9Y4M24D | ||
CY2007Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1636187 | usd |
CY2008 | qprc |
Gain On Subsequent Measurementin Dollars
GainOnSubsequentMeasurementinDollars
|
-1432145 | usd |
CY2008Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
204042 | usd |
us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
The amendment (i) decreased the number of authorized shares of common stock from 10,000,000,000 shares to 30,000,000 shares and (ii) effects a one-for-100 reverse split whereby each share of common stock became and was converted into one-hundredth of a share of such common stock, with fractional shares being rounded up to the next higher whole number of shares. | ||
CY2021Q1 | qprc |
Restructure Agreement Description
RestructureAgreementDescription
|
On February 22, 2021, pursuant to the Restructure Agreement, Intelligent Partners and its controlling members (Fitton and Carper) agreed to extinguish the notes and Transferred Note, and terminate or amend and restate the SPA and Transaction Documents and the Company: (i) issued to Fitton and Carper, as holders of the Transferred Note, pursuant to the Stock Purchase Agreement a total of 462,963 shares of common stock at a purchase price of $0.54 per share, which purchase price was paid by the conversion and in full satisfaction of the Company’s obligation under the Transferred Note and is included in the calculation of the repurchase price of the debt; and (ii) granted Intelligent Partners, pursuant to the Option Grant, an option to purchase a total of 500,000 shares of common stock, with an exercise price of $0.54 per share which vested immediately and may be exercised through September 30, 2025. The Company valued the purchase option at approximately $598,000 using the Black-Scholes pricing model. | |
CY2021Q1 | qprc |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount Rates
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountRates
|
0.0137 | pure |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
2.52 | pure |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2021Q1 | qprc |
Shares Currently Owned
SharesCurrentlyOwned
|
500000 | shares |
CY2021Q1 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
462963 | shares |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
500000 | shares |
CY2021Q1 | us-gaap |
Restricted Cash Nature Of Restriction Description
RestrictedCashNatureOfRestrictionDescription
|
(i) Granted restricted stock grants for services rendered and vesting in full upon grant, to: a.Jon C. Scahill – 490,000 shares b.Timothy J. Scahill – 100,000 shares c.Dr. William R. Carroll – 100,000 shares (ii) Granted Jon Scahill a ten-year option (the “Option”) to purchase 600,000 shares of Common Stock which become exercisable cumulatively as follows: a.200,000 shares at an exercise price of $1.00 per share becoming exercisable upon the commencement of trading of the Common Stock on the OTCQB. b.200,000 shares at an exercise price of $3.00 per share, becoming exercisable on the first day on which the Company files with the SEC a Form 10-K or Form 10-Q which reports stockholders’ equity of at least $5,000,000, and c.200,000 shares at an exercise price of $5.00 per share becoming exercisable on the date on which the Common Stock is listed for trading on the Nasdaq Stock Market or the New York Stock Exchange (iii) Appointed Ryan T. Logue to the board of directors and granted Mr. Logue a restricted stock grant of 500,000 shares of common stock which vested upon his acceptance of his appointment as a director. The Company recognized compensation expense of $888,000 in conjunction with issuance of common stock to officers and directors. The Company determined the fair value of the options to be approximately $720,000 as of the grant date using the Black-Scholes pricing model. Variables used in the valuation include (1) discount rate of 1.37%; (2) term of 10 years; (3) computed volatility of 252% and (4) zero expected dividends. The Company did not recognize any option expense for the three and nine months ended September 30, 2022. The Company recognized option expense of approximately $0 and $240,000 for the three and | |
qprc |
Patent
Patent
|
2757000 | usd | |
CY2021 | qprc |
Patent
Patent
|
5617117 | usd |
qprc |
Patents Weighted Average Amortization Period
PatentsWeightedAverageAmortizationPeriod
|
P11Y7D | ||
CY2021 | us-gaap |
Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
|
-4362117 | usd |
CY2022Q3 | qprc |
Finite Lived Intangible Assets Total
FiniteLivedIntangibleAssetsTotal
|
2757000 | usd |
CY2021Q4 | qprc |
Finite Lived Intangible Assets Total
FiniteLivedIntangibleAssetsTotal
|
1255000 | usd |
CY2022Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-1427345 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-715519 | usd |
CY2022Q3 | qprc |
Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
|
1329655 | usd |
CY2021Q4 | qprc |
Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
|
539481 | usd |
qprc |
Net Value Of Intangible Assets Weighted Average Amortization Period
NetValueOfIntangibleAssetsWeightedAverageAmortizationPeriod
|
P2Y8M1D | ||
us-gaap |
Impaired Intangible Asset Description
ImpairedIntangibleAssetDescription
|
●patents acquired in October 2015 for a purchase price of $3,000,000, the useful lives of the patents, at the date of purchase, was 6-10 years; these patents were disposed of as of December 31, 2021. ●patents acquired in July 2017 pursuant to an obligation to pay 50% of net revenues to IV 34/37 (see Note 3); the useful lives of the patents, at the date of acquisition, was 5-6 years; these patents were disposed of as of December 31, 2021. ●patents (which were fully amortized at the date of acquisition) acquired in January 2018 pursuant to an agreement with to Intellectual Ventures Assets 62 LLC and Intellectual Ventures Assets 71 LLC “(IV 62/71”), pursuant to which CXT has an obligation to distribute 50% of net revenues to IV 62/71; ●patents (which were fully amortized at the date of acquisition) acquired in January 2018 by Photonic Imaging Solutions Inc. (“PIS”) from Intellectual Ventures Assets 64 LLC (“IV 64”) pursuant to which PIS is to pay IV 64 (a) 70% of the first $1,500,000 of net revenue, (b) 30% of the next $1,500,000 of net revenue and (c) 50% of net revenue in excess of $3,000,000; ●patents acquired in March 2019 pursuant to an obligation to pay 50% of net revenues to IV 113/108 (see Note 3); the useful lives of the patents, at the date of acquisition, was approximately 9 years, these patents were disposed of as of December 31, 2021. ●patents (which were fully amortized at the date of acquisition) acquired in May 2020 for a purchase price of $95,000 pursuant to an agreement with Texas Technology Ventures 2, LLP (“TTV”), pursuant to which of the Company retains the first $230,000 of net proceeds, as defined in the agreement, after which the company has an obligation to distribute 50% of net proceeds to TTV. ●patents (which were fully amortized at the date of acquisition) acquired in February 2021 pursuant to an agreement with PKT for a purchase price of $350,000, pursuant to which $350,000 was paid at closing, and upon the realization of gross proceeds, as defined in the agreement, the Company shall make a subsequent or payments in the aggregate amount of $93,900, representing reimbursement to PKT, as the prosecuting attorney, for legal fees associated with prosecution of the portfolio, such reimbursement shall be due and payable to PKT from time to time as gross proceeds are realized, if any, and paid to PKT along with and in proportion to reimbursement to other third parties of costs incurred in realizing gross proceeds. Thereafter, PKT is entitled to a percentage of gross proceeds realized, if any. ●patents acquired in January 2022 for a purchase price of $1,060,000, the useful lives of the patents, at the date of purchase, was approximately 1-2 years. ●patents acquired in July 2022 via assignment from Edward D. Ioli Trust for a purchase price of $92,000, the useful lives of the patents, at the date of purchase, was approximately 2-4 years. ●patents acquired July 2022 pursuant to an agreement with Hewlett Packard Enterprise Development LP and Hewlett Packard Enterprise Company for a purchase price of $350,000. The useful lives of the patents, at the date of purchase, was approximately 2-9 years. | ||
CY2022Q3 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
198000 | usd |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
712000 | usd | |
CY2021Q3 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
139000 | usd |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
1015000 | usd | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
198501 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
457894 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
218352 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
123730 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
83205 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
247973 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1329655 | usd |
CY2022Q3 | qprc |
Cost Of Service
CostOfService
|
33000 | usd |
qprc |
Cost Of Service
CostOfService
|
61000 | usd | |
CY2021Q3 | qprc |
Cost Of Service
CostOfService
|
0 | usd |
qprc |
Cost Of Service
CostOfService
|
0 | usd | |
CY2021Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
usd | |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
us-gaap |
Revenues
Revenues
|
usd | ||
CY2022Q3 | us-gaap |
Other Income
OtherIncome
|
usd | |
CY2022Q3 | qprc |
Warrant Expenses
WarrantExpenses
|
usd | |
CY2022Q3 | qprc |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
usd | |
CY2021Q3 | qprc |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
usd | |
qprc |
Loss On Conversion Of Debt
LossOnConversionOfDebt
|
usd | ||
CY2022Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
usd | |
CY2021Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
usd | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
usd | ||
CY2022Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
usd | ||
us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
usd | ||
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
usd | ||
qprc |
Loss On Conversions Of Debt
LossOnConversionsOfDebt
|
usd | ||
us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
usd | ||
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
usd | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | ||
qprc |
Payments To Acquire Purchase Price Of Patents
PaymentsToAcquirePurchasePriceOfPatents
|
usd | ||
qprc |
Shares Issued For Conversion Of Debt
SharesIssuedForConversionOfDebt
|
usd | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | ||
CY2022Q3 | us-gaap |
Dilutive Securities
DilutiveSecurities
|
usd | |
us-gaap |
Dilutive Securities
DilutiveSecurities
|
usd | ||
us-gaap |
Dilutive Securities
DilutiveSecurities
|
usd | ||
CY2021 | qprc |
Less Unamortized Debt Discount And Issuance Costs
LessUnamortizedDebtDiscountAndIssuanceCosts
|
usd | |
CY2021 | qprc |
Reacquisition Price
ReacquisitionPrice
|
usd | |
qprc |
Fair Value Assumption Expected Dividend Rate
FairValueAssumptionExpectedDividendRate
|
pure | ||
qprc |
Fair Value Assumption Expected Dividend Rate
FairValueAssumptionExpectedDividendRate
|
pure | ||
us-gaap |
Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
|
usd | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000824416 |